Food Allergy: LongBio’s LP-003 achieves its fourth IND approval
SHANGHAI, Nov. 25, 2024 /PRNewswire/ -- LongBio is proud to announce that the National Medical Products Administration (NMPA, China) has approved the Investigational New Drug (IND) application for LP-003, the company's next-generation anti-IgE antibody, to begin a clinical trial for the treatment of food allergy. Food allergy is a growing global health concern, affecting an estimated 2-10% of the population,...
Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts
Twenty studies validate AI performance across diverse populations and clinical settings, including award-winning research in emergency radiology SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced its participation in the Radiological Society of North America (RSNA) 2024 Annual...
Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with ‘Neurophet AQUA’
New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy analysis Accelerating global expansion with cutting-edge technology targeting MS, a prevalent condition in North America and Europe. SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease,...
Lakeside Strengthens Market Position in China’s Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts
ITASCA, Ill., Nov. 25, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), announces that Hupan Pharmaceutical (Hubei) Co., Ltd. ("Hupan Pharmaceutical"), a company recently acquired by Lakeside, has established partnership with...
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson’s Disease
HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. No serious treatment related adverse events were reported and such findings were proportional between placebo and dosed groups. PK results support once a day dosing. ROCKVILLE, Md. and SEOUL, South Korea, Nov. 25, 2024...
LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System
Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings Replaces time-consuming manual spot checking with continuous, near real-time active patient monitoring Web-based system displays multiple patient physiological data continuously, with visual alarms and alert notifications for streamlined patient care Developed to support...
Grand Opening of the Second CREATE Symposium, Exploring New Directions in Smart Healthcare
HONG KONG, Nov. 25, 2024 /PRNewswire/ -- In an era driven by artificial intelligence (AI), the deep integration of advanced technologies into healthcare has become an unstoppable trend. These innovations are reshaping the industry, accelerating transformation, and driving unprecedented breakthroughs. From November 22 to 23, 2024, the 2nd Hong Kong Clinical-driven Robotics and Embodied AI TEchnology Symposium (CREATE Symposium),...
J INTS BIO and MD Anderson Collaborate on the Development of Brain Tumor Treatment ‘JIN-001’ – Enhancing Radiation and Chemotherapy Efficacy
SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- J INTS BIO announced research findings on its innovative brain tumor treatment, 'JIN-001,' developed in collaboration with MD Anderson Cancer Center, at the 2024 Society of Neuro-Oncology (SNO) Annual Meeting in Texas, USA. MD Anderson is a globally renowned cancer research institution, and J INTS BIO has partnered with it since...
Smartee Introduces Facial Convexity and Deviation Solutions in Vietnam
HO CHI MINH CITY, Vietnam, Nov. 25, 2024 /PRNewswire/ -- The 4th Scientific Meeting of the Ho Chi Minh City Association of Orthodontists recently took place at The Reverie Saigon Hotel in Vietnam. The theme was "Orthodontic Management of Growing Patients." Over 400 doctors attended to exchange industry insights. Smartee Denti-Technology's Chief Scientist, Prof. Gang Shen,...
Veeva Announces AI in Vault CRM
CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM. Unveiled at Veeva Commercial Summit Europe, CRM Bot and Voice Control join a host...
